Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
1.350
-0.090 (-6.25%)
Jan 22, 2025, 12:53 PM EST - Market open
Kazia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jan '25 Jan 22, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Market Capitalization | 6 | 7 | 26 | 58 | 128 | 32 | |
Market Cap Growth | -74.25% | -74.25% | -54.61% | -54.40% | 298.54% | 98.02% | |
Enterprise Value | 6 | 5 | 24 | 47 | 113 | 28 | |
Last Close Price | 1.44 | 2.29 | 11.60 | 42.00 | 98.60 | 33.90 | |
PS Ratio | 2.29 | 4.11 | 39743.19 | 8458.36 | 11.23 | 47.01 | |
PB Ratio | -1.02 | -1.02 | 3.30 | 4.63 | 4.50 | 3.29 | |
P/TBV Ratio | - | - | - | - | 10.76 | 27.08 | |
EV/Sales Ratio | 3.38 | 2.80 | 35823.59 | 6855.41 | 9.92 | 40.38 | |
Debt / Equity Ratio | -0.06 | -0.06 | 0.15 | 0.10 | - | - | |
Asset Turnover | 0.10 | 0.10 | 0.00 | 0.00 | 0.37 | 0.04 | |
Quick Ratio | 0.07 | 0.07 | 0.71 | 1.10 | 3.32 | 1.97 | |
Current Ratio | 0.24 | 0.24 | 1.42 | 1.40 | 3.53 | 2.10 | |
Return on Equity (ROE) | -2634.33% | -2634.33% | -134.97% | -89.14% | -32.41% | -88.05% | |
Return on Assets (ROA) | -71.63% | -71.63% | -47.18% | -33.76% | -9.82% | -34.45% | |
Return on Capital (ROIC) | -797.17% | -797.17% | -88.87% | -54.74% | -15.34% | -53.82% | |
Earnings Yield | -284.90% | -262.32% | -51.49% | -29.57% | -4.94% | -26.84% | |
FCF Yield | -96.06% | -93.86% | -38.13% | -26.91% | -5.34% | -18.97% | |
Buyback Yield / Dilution | -43.08% | -43.08% | -39.12% | -12.57% | -61.08% | -27.04% | |
Total Shareholder Return | -43.08% | -43.08% | -39.12% | -12.57% | -61.08% | -27.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.